Media and events

Inspired by the venom of deadly snakes, RAPClot technology aims to optimise patient outcomes.

Professor Linda Lua, Director of the Protein Expression Facility housed at AIBN, is developing a new vaccine candidate for avian influenza.

Vaccine technology being developed at The University of Queensland could hold the key to completely eradicating polio by removing live virus from the vaccine production process.

UQ’s Protein Expression Facility director, Associate Professor Linda Lua, said ­future research may also show that Zika virus synthetic proteins are an effective way to induce an immune response, paving the way for tailored treatments.

Awarded to those who have made outstanding and significant contribution to delivering excellence in service to students, staff or the wider community.

Queensland Health–UQ collaborative aimed at better diagnosing Zika virus

Researchers are developing a vaccine to reduce the staggering level of infant mortality from rotavirus in developing countries.